nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in antibody–drug conjugates: A new era of targeted cancer therapy
|
Sau, Samaresh |
|
2017 |
22 |
10 |
p. 1547-1556 |
artikel |
2 |
Contents page 1
|
|
|
2017 |
22 |
10 |
p. i |
artikel |
3 |
Contents page 2
|
|
|
2017 |
22 |
10 |
p. ii |
artikel |
4 |
Curcumin and its topical formulations for wound healing applications
|
Mohanty, Chandana |
|
2017 |
22 |
10 |
p. 1582-1592 |
artikel |
5 |
Current progress in antivascular tumor therapy
|
Ho, Yi-Ju |
|
2017 |
22 |
10 |
p. 1503-1515 |
artikel |
6 |
Developing PreDICT – a fully integrated data platform for preclinical in vivo data: learning from experience
|
Jones, Rhys D.O. |
|
2017 |
22 |
10 |
p. 1539-1546 |
artikel |
7 |
Efficacy of non-vitamin-K antagonist oral anticoagulants for intracardiac thrombi resolution in nonvalvular atrial fibrillation
|
Orenes-Piñero, Esteban |
|
2017 |
22 |
10 |
p. 1565-1571 |
artikel |
8 |
From flamingo dance to (desirable) drug discovery: a nature-inspired approach
|
Sánchez-Rodríguez, Aminael |
|
2017 |
22 |
10 |
p. 1489-1502 |
artikel |
9 |
Improving the economics of NASH/NAFLD treatment through the use of systems biology
|
Bosley, Jim |
|
2017 |
22 |
10 |
p. 1532-1538 |
artikel |
10 |
Industrial medicinal chemistry insights: neuroscience hit generation at Janssen
|
Tresadern, Gary |
|
2017 |
22 |
10 |
p. 1478-1488 |
artikel |
11 |
Leishmaniasis drug discovery: recent progress and challenges in assay development
|
Zulfiqar, Bilal |
|
2017 |
22 |
10 |
p. 1516-1531 |
artikel |
12 |
Progranulin as a biomarker and potential therapeutic agent
|
Abella, Vanessa |
|
2017 |
22 |
10 |
p. 1557-1564 |
artikel |
13 |
Targeting survivin for therapeutic discovery: past, present, and future promises
|
Peery, Robert C. |
|
2017 |
22 |
10 |
p. 1466-1477 |
artikel |
14 |
The 1,2,3-triazole ring as a bioisostere in medicinal chemistry
|
Bonandi, Elisa |
|
2017 |
22 |
10 |
p. 1572-1581 |
artikel |
15 |
Thorough QT (TQT) studies: concordance with torsadogenesis and an evolving cardiac safety testing paradigm
|
Wiśniowska, Barbara |
|
2017 |
22 |
10 |
p. 1460-1465 |
artikel |
16 |
Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective
|
Wong, Harvey |
|
2017 |
22 |
10 |
p. 1447-1459 |
artikel |